聯系電話
上海起發實驗試劑有限公司
中級會員·16年上海起發實驗試劑有限公司
中級會員·16年聯系電話
當前位置：> 供求商機> macrocyclics報價表
掃一掃訪問手機商鋪
Macrocyclics，Macrocyclics代理，Macrocyclics上海代理，美國Macrocyclics，Macrocyclics總代理
Macrocyclics總部位于美國，Macrocyclics專業生產大環聚合物和為客戶提供螯合劑定制服務，Macrocyclics致力于發展新的螯合化學平臺。Macrocyclics產品涉單克隆抗體和肽片段。以下為Macrocyclics部分產品。
上海起福生物科技有限公司Macrocyclics專業代理，具體產品信息歡迎電詢：
| 品牌 | 貨號 | 品名 | CAS | 價格￥ | 規格 |
| macrocyclics | B-1005 | p-SCN-Bn-TCMC | 282097-63-6 | 5610 | 50 mg |
| macrocyclics | B-1005 | p-SCN-Bn-TCMC | 282097-63-6 | 10370 | 100 mg |
| macrocyclics | B-110 | p-NO2-Bn-Cyclen | 116052-96-9 | 6103 | 100 mg |
| macrocyclics | B-110 | p-NO2-Bn-Cyclen | 116052-96-9 | 27336 | 500 mg |
| macrocyclics | B-199 | p-NO2-Bn-DOTA | 116052-88-1 | 4318 | 50 mg |
| macrocyclics | B-199 | p-NO2-Bn-DOTA | 116052-88-1 | 6902 | 100 mg |
| macrocyclics | B-200 | p-NH2-Bn-DOTA | 181065-46-3 | 4250 | 50 mg |
| macrocyclics | B-200 | p-NH2-Bn-DOTA | 181065-46-3 | 6800 | 100 mg |
| macrocyclics | B-200 | p-NH2-Bn-DOTA | 181065-46-3 | 27421 | 500 mg |
| macrocyclics | B-201 | p-NH2-Bn-DOTA-tetra（t-Bu-ester） | 13056 | 100 mg | |
| macrocyclics | B-201 | p-NH2-Bn-DOTA-tetra（t-Bu-ester） | 40154 | 500 mg | |
| macrocyclics | B-205 | p-SCN-Bn-DOTA | 127985-74-4 | 5508 | 50 mg |
| macrocyclics | B-205 | p-SCN-Bn-DOTA | 127985-74-4 | 8364 | 100 mg |
| macrocyclics | B-205 | p-SCN-Bn-DOTA | 127985-74-4 | 32402 | 500 mg |
| macrocyclics | B-260 | DOTA-tris （t-Bu ester） | 137076-54-1 | 8636 | 500 mg |
| macrocyclics | B-260 | DOTA-tris （t-Bu ester） | 137076-54-1 | 13464 | 1 gm |
| macrocyclics | B-260 | DOTA-tris （t-Bu ester） | 137076-54-1 | 58837 | 5 gm |
| macrocyclics | B-270 | DOTA-mono-NHS-tris（t-Bu ester） | 819869-77-7 | 3298 | 100 mg |
| macrocyclics | B-270 | DOTA-mono-NHS-tris（t-Bu ester） | 819869-77-7 | 13396 | 500 mg |
| macrocyclics | B-270 | DOTA-mono-NHS-tris（t-Bu ester） | 819869-77-7 | 22865 | 1 gm |
| macrocyclics | B-271 | Maleimido-mono-amide-DOTA-tris （t-Bu ester） | 3230 | 50 mg | |
| macrocyclics | B-271 | Maleimido-mono-amide-DOTA-tris （t-Bu ester） | 5168 | 100 mg | |
| macrocyclics | B-271 | Maleimido-mono-amide-DOTA-tris （t-Bu ester） | 15249 | 500 mg | |
| macrocyclics | B-272 | Maleimido-mono-amide-DOTA | 1006711-09-5 | 3723 | 50 mg |
| macrocyclics | B-272 | Maleimido-mono-amide-DOTA | 1006711-09-5 | 5916 | 100 mg |
| macrocyclics | B-272 | Maleimido-mono-amide-DOTA | 1006711-09-5 | 17663 | 500 mg |
| macrocyclics | B-275 | Fmoc-L-Lys-mono-amide-DOTA-tris（t-Bu ester） | 479081-06-6 | 3179 | 50 mg |
| macrocyclics | B-275 | Fmoc-L-Lys-mono-amide-DOTA-tris（t-Bu ester） | 479081-06-6 | 4981 | 100 mg |
| macrocyclics | B-275 | Fmoc-L-Lys-mono-amide-DOTA-tris（t-Bu ester） | 479081-06-6 | 15147 | 500 mg |
| macrocyclics | B-277 | 2-Aminoethyl-mono-amide-DOTA-tris（t-Bu ester） | 8789 | 500 mg | |
| macrocyclics | B-277 | 2-Aminoethyl-mono-amide-DOTA-tris（t-Bu ester） | 15793 | 1 gm | |
| macrocyclics | B-277 | 2-Aminoethyl-mono-amide-DOTA-tris（t-Bu ester） | 62764 | 5 gm | |
| macrocyclics | B-278 | Azido-mono-amide-DOTA-tris（t-butyl ester） | 3230 | 100 mg | |
| macrocyclics | B-278 | Azido-mono-amide-DOTA-tris（t-butyl ester） | 12903 | 500 mg | |
| macrocyclics | B-278 | Azido-mono-amide-DOTA-tris（t-butyl ester） | 23460 | 1 gm | |
| macrocyclics | B-280 | DOTA-NHS-ester | 170908-81-3 | 3723 | 100 mg |
| macrocyclics | B-280 | DOTA-NHS-ester | 170908-81-3 | 14484 | 500 mg |
| macrocyclics | B-280 | DOTA-NHS-ester | 170908-81-3 | 25959 | 1 gm |
| macrocyclics | B-288 | Azido-mono-amide-DOTA | 4522 | 100 mg | |
| macrocyclics | B-288 | Azido-mono-amide-DOTA | 18071 | 500 mg | |
| macrocyclics | B-288 | Azido-mono-amide-DOTA | 32844 | 1 gm | |
| macrocyclics | B-300 | p-NH2-Bn-DTPA | 102650-29-3 | 2516 | 100 mg |
| macrocyclics | B-300 | p-NH2-Bn-DTPA | 102650-29-3 | 10863 | 500 mg |
| macrocyclics | M-100 | Cyclen | 294-90-6 | 4165 | 5 gm |
| macrocyclics | M-100 | Cyclen | 294-90-6 | 7905 | 10 gm |
| macrocyclics | M-100 | Cyclen | 294-90-6 | 18275 | 25 gm |
| macrocyclics | M-110 | Cyclam | 295-37-4 | 1020 | 500 mg |
| macrocyclics | M-110 | Cyclam | 295-37-4 | 1428 | 1 gm |
| macrocyclics | M-125 | DO2A | 91987-74-5 | 7718 | 500 mg |
| macrocyclics | M-125 | DO2A | 91987-74-5 | 13957 | 1 gm |
| macrocyclics | M-140 | DOTA | 60239-18-1 | 2448 | 1 gm |
| macrocyclics | M-140 | DOTA | 60239-18-1 | 10421 | 5 gm |
| macrocyclics | M-140 | DOTA | 60239-18-1 | 43129 | 25 gm |
| macrocyclics | M-150 | DOTP | 91987-74-5 | 1394 | 1 gm |
| macrocyclics | M-150 | DOTP | 91987-74-5 | 4454 | 5 gm |
| macrocyclics | M-150 | DOTP | 91987-74-5 | 8262 | 10 gm |
| macrocyclics | M-160 | DOTMA | 148408-89-3 | 2703 | 100 mg |
| macrocyclics | M-160 | DOTMA | 148408-89-3 | 8432 | 500 mg |
| macrocyclics | M-160 | DOTMA | 148408-89-3 | 15062 | 1 gm |
| macrocyclics | M-170 | TETA | 314041-07-1 | 7871 | 500 mg |
| macrocyclics | M-170 | TETA | 314041-07-1 | 14365 | 1 gm |
| macrocyclics | M-170 | TETA | 314041-07-1 | 59993 | 5 gm |
| macrocyclics | M-165 | Tm-DOTMA | 13090 | 500 mg | |
| macrocyclics | M-165 | Tm-DOTMA | 20400 | 1 gm | |
| macrocyclics | M-503 | Eu-DOTA-4AmC | 2550 | 50 mg | |
| macrocyclics | M-503 | Eu-DOTA-4AmC | 4505 | 100 mg | |
| macrocyclics | M-503 | Eu-DOTA-4AmC | 10370 | 500 mg | |
| macrocyclics | I-121 | BisCBZ-Cyclen | 4896 | 1 gm | |
| macrocyclics | I-121 | BisCBZ-Cyclen | 19448 | 5 gm | |
| macrocyclics | I-131 | TrisBOC-Cyclen | 4301 | 1 gm | |
| macrocyclics | I-131 | TrisBOC-Cyclen | 19363 | 5 gm | |
| macrocyclics | M-120 | DO2A-t-Bu-ester | 162148-48-3 | 6783 | 500 mg |
| macrocyclics | M-120 | DO2A-t-Bu-ester | 162148-48-3 | 12648 | 1 gm |
| macrocyclics | M-120 | DO2A-t-Bu-ester | 162148-48-3 | 41497 | 5 gm |
| macrocyclics | M-130 | DO3A-t-Bu-ester | 122555-91-3 | 4216 | 500 mg |
| macrocyclics | M-130 | DO3A-t-Bu-ester | 122555-91-3 | 7905 | 1 gm |
| macrocyclics | M-130 | DO3A-t-Bu-ester | 122555-91-3 | 37961 | 5 gm |
| macrocyclics | M-180 | DOTAM | 3213 | 500 mg | |
| macrocyclics | M-180 | DOTAM | 5219 | 1 gm | |
| macrocyclics | M-180 | DOTAM | 21386 | 5 gm | |
| macrocyclics | M-190 | DiAmSar | 91002-72-1 | 4896 | 100 mg |
| macrocyclics | M-190 | DiAmSar | 91002-72-1 | 16133 | 500 mg |
| macrocyclics | M-200 | CB-Cyclam | 130701-19-8 | 12716 | 500 mg |
| macrocyclics | M-200 | CB-Cyclam | 130701-19-8 | 19550 | 1 gm |
| macrocyclics | M-220 | CB-TE2A | 91987-74-5 | 3519 | 100 mg |
| macrocyclics | M-220 | CB-TE2A | 91987-74-5 | 15640 | 500 mg |
| macrocyclics | M-600 | NOTA | 56491-86-2 | 8806 | 500 mg |
| macrocyclics | M-600 | NOTA | 56491-86-2 | 12716 | 1 gm |
| macrocyclics | M-90 | TACN | 4896 | 1 gm | |
| macrocyclics | M-90 | TACN | 19448 | 5 gm | |
| macrocyclics | M-145 | Tm-DOTA | 3519 | 500 mg | |
| macrocyclics | M-145 | Tm-DOTA | 6460 | 1 gm | |
| macrocyclics | M-147 | Gd-DOTA | 3145 | 500 mg | |
| macrocyclics | M-147 | Gd-DOTA | 5610 | 1 gm | |
| macrocyclics | M-155 | Tm[DOTP]5- | 30859-88-8 | 2499 | 1 gm |
| macrocyclics | M-155 | Tm[DOTP]5- | 30859-88-8 | 20519 | 10 gm |
| macrocyclics | M-155 | Tm[DOTP]5- | 30859-88-8 | 193545 | 100 gm |
| macrocyclics | B-301 | p-NH2-Bn-DTPA-penta （t-Bu ester） | 205956-41-0 | 21403 | 1 gm |
| macrocyclics | B-305 | p-SCN-Bn-DTPA | 102650-30-6 | 3094 | 100 mg |
| macrocyclics | B-305 | p-SCN-Bn-DTPA | 102650-30-6 | 13651 | 500 mg |
| macrocyclics | B-351 | p-NH2-CHX-A"-DTPA | 6256 | 100 mg | |
| macrocyclics | B-351 | p-NH2-CHX-A"-DTPA | 24242 | 500 mg | |
| macrocyclics | B-355 | CHX-A''-DTPA | 157380-45-5 | 4624 | 50 mg |
| macrocyclics | B-355 | CHX-A''-DTPA | 157380-45-5 | 7038 | 100 mg |
| macrocyclics | B-355 | CHX-A''-DTPA | 157380-45-5 | 25908 | 500 mg |
| macrocyclics | B-365 | DTPA-tetra （t-Bu ester） | 174267-71-1 | 11305 | 500 mg |
| macrocyclics | B-365 | DTPA-tetra （t-Bu ester） | 174267-71-1 | 20808 | 1 gm |
| macrocyclics | B-372 | Maleimido-mono-amide-DTPA | 5440 | 50 mg | |
| macrocyclics | B-372 | Maleimido-mono-amide-DTPA | 8704 | 100 mg | |
| macrocyclics | B-372 | Maleimido-mono-amide-DTPA | 29716 | 500 mg | |
| macrocyclics | B-401 | p-NH2-Bn-PCTA | 6069 | 50 mg | |
| macrocyclics | B-401 | p-NH2-Bn-PCTA | 8806 | 100 mg | |
| macrocyclics | B-405 | p-SCN-Bn-PCTA | 7395 | 50 mg | |
| macrocyclics | B-405 | p-SCN-Bn-PCTA | 10013 | 100 mg | |
| macrocyclics | B-501 | p-NH2-Bn-oxo-DO3A | 6069 | 50 mg | |
| macrocyclics | B-501 | p-NH2-Bn-oxo-DO3A | 8806 | 100 mg | |
| macrocyclics | B-505 | p-SCN-Bn-oxo-DO3A | 7208 | 50 mg | |
| macrocyclics | B-505 | p-SCN-Bn-oxo-DO3A | 9758 | 100 mg | |
| macrocyclics | B-601 | p-NH2-Bn-NOTA | 142131-37-1 | 3876 | 50 mg |
| macrocyclics | B-601 | p-NH2-Bn-NOTA | 142131-37-1 | 6630 | 100 mg |
| macrocyclics | B-605 | p-SCN-Bn-NOTA | 147597-66-8 | 5831 | 50 mg |
| macrocyclics | B-605 | p-SCN-Bn-NOTA | 147597-66-8 | 8806 | 100 mg |
| macrocyclics | B-705 | Deferoxamine-p-SCN | 4386 | 50 mg | |
| macrocyclics | B-705 | Deferoxamine-p-SCN | 6919 | 100 mg | |
| macrocyclics | B-705 | Deferoxamine-p-SCN | 23885 | 500 mg | |
| macrocyclics | B-772 | Deferoxamine-maleimide | 3570 | 50 mg | |
| macrocyclics | B-772 | Deferoxamine-maleimide | 5627 | 100 mg | |
| macrocyclics | B-772 | Deferoxamine-maleimide | 19397 | 500 mg | |
| macrocyclics | C-100 | DOTA-Biotin-Sarcosine | 6596 | 20 mg | |
| macrocyclics | C-100 | DOTA-Biotin-Sarcosine | 13838 | 50 mg | |
| macrocyclics | C-100 | DOTA-Biotin-Sarcosine | 26979 | 100 mg | |
| macrocyclics | S-100 | Samplet Pack- Bifunctionals | 13583 | Standard |
上海起發實驗試劑有限公司
：楊建輝
：
辦公：
*8006
:
:http://www.qfbio。。ｃｏｍ/
地址：上海市浦東新區繡川路561號1102室
上海起發實驗試劑有限公司 - 主營產品： 線性聚乙烯亞胺PEI,硫酸葡聚糖 DSS
化工儀器網設計制作，未經允許翻錄必究 Copyright(C) http://m.js967.com All rights reserved
以上信息由企業自行提供，信息內容的真實性、準確性和合法性由相關企業負責，化工儀器網對此不承擔任何保證責任。請輸入賬號
請輸入密碼
請輸驗證碼
